KZR Insider Trading Activity and SEC Form 4 Filings
KZR insider trading summary
No open-market insider purchases or sales of Kezar Life Sciences, Inc. (KZR) have been reported on SEC Form 4 in the past 12 months.
Latest KZR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2025 | Pichi Luo Chiang | SVP, Corporate Controller | Sell | $1K (264 @ $4.28) |
| Jul 2, 2025 | Mark C. Schiller | Chief Operating Officer | Sell | $2K (561 @ $4.28) |
| Jul 2, 2024 | Mark C. Schiller | Chief Legal Officer | Sell | $4K (6,688 @ $0.58) |
| Feb 6, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $275K (40,000 @ $6.88) |
| Feb 3, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $179K (25,000 @ $7.15) |
| Feb 2, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $360K (50,000 @ $7.19) |
| Feb 1, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $278K (40,000 @ $6.95) |
| Jan 31, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $212K (30,000 @ $7.08) |
| Jan 30, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $207K (30,000 @ $6.91) |
| Jan 25, 2023 | Morningside Venture Investments Ltd | 10% Owner | Sell | $343K (50,000 @ $6.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.